C. van Oordt

Safety and efficacy of Temsirolimus in combination with Bendamustine and Rituximab in relapsed mantle cell and follicular lymphoma

W. Klapper, C. Buske, M. Dreyling, 2015, Leukemia.

Final Results of a Phase I/II Trial of the Combination Bendamustine and Rituximab With Temsirolimus (BeRT) in Relapsed Mantle Cell Lymphoma and Follicular Lymphoma

W. Klapper, M. Dreyling, G. Hess, 2020, HemaSphere.